心脏骤停复苏后目标导向低正常或高正常平均动脉压:一项随机预试验
COMACARE试验采用2×3析因设计,将院外心脏骤停复苏后患者随机分配至低正常或高正常平均动脉压目标。本文报告低正常(65–75 mmHg)与高正常(80–100 mmHg)平均动脉压比较结果,纳入123例、最终分析120例。两组平均动脉压分离清晰(p<0.001),但48小时血清神经元特异性烯醇化酶中位数低正常组20.6 µg/L(15.2–34.9 µg/L)与高正常组22.0 µg/L(13.6–30.9 µg/L)无差异(p=0.522),次要结局亦无差异。结论认为复苏后重症监护期间目标导向平均动脉压管理可行,但血压水平未影响48小时神经元特异性烯醇化酶浓度或任何次要结局。
要点
- 院外心脏骤停复苏后,低正常平均动脉压目标(65–75 mmHg)与高正常目标(80–100 mmHg)均可行,两组平均动脉压分离清晰(p<0.001)。
- 48小时血清神经元特异性烯醇化酶中位数:低正常平均动脉压组20.6 µg/L(15.2–34.9 µg/L)vs 高正常组22.0 µg/L(13.6–30.9 µg/L),p=0.522。
- S100B蛋白、肌钙蛋白T、脑电图、脑氧合及6个月神经功能结局等次要结局在两组间均无差异。
- 最终分析纳入120例院外心脏骤停复苏后患者,随机分组比较低正常与高正常平均动脉压目标。
适用人群与场景
- 院外心脏骤停并复苏成功的患者,随机分配至低正常或高正常平均动脉压目标。
- 最终分析纳入120例(共招募123例)。
处置流程与药物剂量
- 低正常平均动脉压目标:65–75 mmHg。
- 高正常平均动脉压目标:80–100 mmHg。
- 在复苏后重症监护期间实施目标导向平均动脉压管理。
研究设计与关键结果
- COMACARE试验采用2×3析因设计,将院外心脏骤停复苏后患者随机分配至低正常或高正常动脉二氧化碳分压、正常氧或中度高氧、以及低正常或高正常平均动脉压。
- 本文报告低正常(65–75 mmHg)vs 高正常(80–100 mmHg)平均动脉压比较,招募123例、最终分析120例。
- 两组平均动脉压分离清晰(p<0.001)。
- 主要结局48小时血清神经元特异性烯醇化酶中位数:低正常平均动脉压组20.6 µg/L(15.2–34.9 µg/L)vs 高正常组22.0 µg/L(13.6–30.9 µg/L),p=0.522。
- 次要结局包括S100B蛋白、肌钙蛋白T、脑电图、脑氧合及6个月神经功能结局,两组间均无差异。
证据类型、等级与局限
- 证据类型:随机预试验(2×3析因设计)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 复苏后重症监护期间,将平均动脉压目标设定在低正常(65–75 mmHg)或高正常(80–100 mmHg)范围均可行,但血压水平未影响48小时神经元特异性烯醇化酶浓度或任何次要结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to determine the feasibility of targeting low-normal or high-normal mean arterial pressure (MAP) after out-of-hospital cardiac arrest (OHCA) and its effect on markers of neurological injury.
METHODS: In the Carbon dioxide, Oxygen and Mean arterial pressure After Cardiac Arrest and REsuscitation (COMACARE) trial, we used a 23 factorial design to randomly assign patients after OHCA and resuscitation to low-normal or high-normal levels of arterial carbon dioxide tension, to normoxia or moderate hyperoxia, and to low-normal or high-normal MAP. In this paper we report the results of the low-normal (65-75 mmHg) vs. high-normal (80-100 mmHg) MAP comparison. The primary outcome was the serum concentration of neuron-specific enolase (NSE) at 48 h after cardiac arrest. The feasibility outcome was the difference in MAP between the groups. Secondary outcomes included S100B protein and cardiac troponin (TnT) concentrations, electroencephalography (EEG) findings, cerebral oxygenation and neurological outcome at 6 months after cardiac arrest.
RESULTS: We recruited 123 patients and included 120 in the final analysis. We found a clear separation in MAP between the groups (p < 0.001). The median (interquartile range) NSE concentration at 48 h was 20.6 µg/L (15.2-34.9 µg/L) in the low-normal MAP group and 22.0 µg/L (13.6-30.9 µg/L) in the high-normal MAP group, p = 0.522. We found no differences in the secondary outcomes.
CONCLUSIONS: Targeting a specific range of MAP was feasible during post-resuscitation intensive care. However, the blood pressure level did not affect the NSE concentration at 48 h after cardiac arrest, nor any secondary outcomes.
参考来源
- Jakkula P, Pettilä V, Skrifvars MB, et al. Targeting low-normal or high-normal mean arterial pressure after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Med. 2018. PMID: 30443729. doi:10.1007/s00134-018-5446-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。